Interferon Resistance in Hepatitis C Virus Replicon
Author Information
Author(s): Hazari Sidhartha, Taylor Lizeth, Haque Salima, Garry Robert F, Florman Sander, Luftig Ronald, Regenstein Frederic, Dash Srikanta
Primary Institution: Tulane University Health Sciences Center
Hypothesis
The study aims to determine the contribution of host cell factors to the mechanisms of interferon resistance using replicon cell lines.
Conclusion
The study provides evidence that altered expression of Jak-Stat signaling proteins can cause interferon resistance in HCV replicon cell clones.
Supporting Evidence
- HCV replicons with low activation of the IFN-promoter developed resistance to interferon treatment.
- All resistant cell lines maintained high levels of viral RNA and protein expression after interferon treatment.
- Reduced expression of Jak-1 and Tyk-2 proteins was observed in all interferon resistant cell lines.
Takeaway
Some cells infected with the hepatitis C virus can resist treatment with interferon, and this resistance is linked to changes in certain proteins in the cells.
Methodology
The study involved culturing HCV replicons with different levels of interferon promoter activation and isolating stable replicon cell lines to assess their resistance to interferon.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website